Class IIReported 2025-10-29

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46

Recalled by Lannett Company Inc.

Reason for Recall

Failed Dissolution Specifications

Recall Number

D-0096-2026

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-10-10

Reported

2025-10-29

Distribution

Nationwide in the USA

Code Info

Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A, Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.